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Abstract 
 
Research is the necessary foundation for health care advancement and understanding. 
Significant challenges exist, however, with recruiting and engaging underrepresented 
populations in clinical research. The purpose of the scholarly project was to determine how 
stakeholder race, trust, and level of education influence participation barriers in clinical research. 
The project utilized secondary, cross sectional survey data that were collected between 2014 and 
2016 through the former Mid-South Clinical Data Research Network (CDRN), currently known 
as the STAR-CRN. Descriptive statistics and spearman rank correlations were performed 
between level of education, level of trust, and each attitude statement for each racial category. A 
total of 2,149 survey responses were used in the data analysis. The mean age of respondents was 
52 years old (SD=15.65) with majority being female (69.0%, n=1496), white (77.7%, n=1701), 
insured (76%, n=1610), and working full time (50.4%, n=1078). Overall, the respondents had 
favorable attitudes towards research participation. Trust was associated with agreement in each 
attitude statement from both white and AA respondents (p<.001), while correlations with 
education level was more variable depending on racial grouping. Trust level was negatively 
associated with agreement towards the statement “Researchers don’t care about me” in White 
(CC=-.492; p=.000), AA (CC=-.188; p=.000), Asian (CC=-.429; p=.041), and Middle Eastern 
(CC=-.864; p=.003) respondents. The results support the importance of trust within the patient 
and provider relationship. Generally, education level is not a largely predictive variable in its 
influence of research participation, although it shows stronger evidence of influence depending 
on race and attitude statement. 
Keywords: trust, race, education, participation, clinical research, underrepresented, adults 
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Predictors of barriers to participation in clinical research 
in adults living in the Southeastern United States 
Introduction and Background 
At the turn of the 21st century, the Institute of Medicine (IOM) released the article, 
Crossing the Quality Chasm, which emphasized the need for an effective, equitable, and patient-
centered health care delivery system (Agency for Healthcare Research and Quality [AHRQ], 
2018). Effective health care refers to providing appropriate medical services based on scientific 
knowledge to those who could benefit, while refraining from services that are likely 
nonbeneficial (AHRQ, 2018).  Equitable health care does not vary in quality based on patient-
specific characteristics like race, socio-economic status, or geographic location (AHRQ, 2018). 
Patient-centered care (PCC) views a patient holistically and is grounded in the idea of mutuality 
between the patient and medical provider. The goal is to ultimately attain the best health 
outcomes for the patient (Beattie, Shepherd, Howieson, 2012). In order to provide effective and 
equitable care to all individuals, health care research in the domain of patient centeredness is 
necessary (Beattie et al., 2012).  
Health care research is a general term that includes a variety of research methodologies 
that ultimately develop or provide knowledge regarding disease, risk factors, outcomes of 
treatment, public health interventions, functional abilities, patterns of care, and health care usage 
(Beattie et al., 2012). For example, a medical provider may decide to treat a young African 
American woman with hypertension differently compared to an older Caucasian woman based 
on what research shows to be most effective. It is through research that the goal of equitable, 
effective, and patient centered health care can be attained. 
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Although research is the necessary foundation for health care advancement and 
understanding, significant challenges exist with recruiting and engaging underrepresented 
populations into health care research. The National Institutes of Health (NIH) recognize African 
Americans (AA), American Indians (AI), Alaskan Natives (AN), Hispanics, Native Hawaiians 
(NH), and other Pacific Islanders (PI) as underrepresented populations in research studies 
(National Institutes of Health [NIH], 2018). Although increasing minority participation in 
clinical trials has been a priority in the country since the NIH Revitalization Act of 1993, 
participation rates in minority populations remain low compared to the percentage of minorities 
in the entire United States’ (US) population (Reifenstein & Asare, 2018).  
In 2017, the FDA reported 81% of clinical trial participants as Caucasian, 14% AA, 2.7% 
Asian, and the remaining 2.3% were Hispanic, PI, AI, AN, and NH populations (Food and Drug 
Administration [FDA], 2017). The participants were not representative of the entire US 
population in that 61% were Caucasian, 18% were Hispanic or Latino and 15% were African 
American, 5% were Asian, and 2% were AI or PI (United States Census Bureau, 2017). 
Although minority populations are underrepresented in clinical research, they face the greatest 
health disparities (AHRQ, 2015). 
The 2015 National Healthcare Quality and Disparities Report documents that minority 
populations receive poorer quality of care and face greater barriers in accessing care compared to 
white populations (AHRQ, 2015). In addition, AA, AI, and Hispanics have greater rates of 
preventable hospitalizations and higher mortality rates compared to white populations (AHRQ, 
2015). Incidence of specific diseases, cancers, and reactions to medications and treatments differ 
between races and ethnicities. For example, AA men have a greater incidence of prostate cancer 
compared to Caucasian men. AA women have the same incidence of breast cancer as Caucasian 
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women, however, have higher mortality rates (Ahaghotu, Tyler, & Sartor, 2015; Reifenstein & 
Asare, 2018). In addition, Hispanics and AAs have the greatest prevalence of diabetes and 
adolescent obesity compared to Caucasians (CDC, 2015). Similarly, almost half of all AA adults 
have some form of cardiovascular disease compared to about one third of Caucasian adults 
(Reifenstein & Asare, 2018). In addition to health disparities, the effectiveness of treatment 
modalities differs between races. Clopidogrel, an antiplatelet drug is highly effective for 
Caucasians but has no greater affect than a placebo in 75% of Pacific Islanders (Wu, White, Oh 
& Buchard, 2015). Due to the disparities present, it is necessary to recruit and engage diverse 
populations in order to create equitable health systems. However, engaging and recruiting 
participants to accurately represent the diversity of the population is challenging process 
(Cunningham-Erves et al., 2017). 
Problem Statement 
 Research participants, also referred to as stakeholders in patient centered research studies, 
are needed from diverse populations (i.e. racial ethnic minorities, sexual gender minorities, 
variation in geographic locations and differing abilities) in order to identify relationships 
between numerous socio-cultural and biologic variables, ensure reliable data, and to ultimately 
determine equitable, effective, and patient-centered health outcomes and solutions for all patients 
(Centers for Disease Control [CDC], 2013; Cunningham-Erves et al., 2017; FDA, 2018; Lin & 
Kelsey, 2000). Although there is a great need in engaging diverse samples of participants for 
research as mentioned previously, recruiting and engaging participants remains a challenge.  
In 2014, the National Patient-Centered Clinical Research Network was established by the 
Patient-Centered Outcomes Research Institute (PCORI) with the goal of transforming the culture 
of clinical research through patient-centered engagement and recruitment (Unertl et al., 2018). 
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Utilizing the multiple healthcare facilities and millions of patients in the network, the STAR-
CRN (Stakeholders, Technology, and Research CRN, n.d.), formally known as the Mid-South 
Clinical Data Research Network (CDRN), a sub-unit of the National Patient-Centered Clinical 
Research Network, aims to increase the number of research participants through their diverse 
patient network. In order to effectively engage patients in the diverse STAR-CRN network, it is 
necessary to identify the barriers that these specific patients encounter at any point in the 
research process.  
Purpose and Hypothesis 
The purpose of the scholarly project was to determine how stakeholder race, trust, and level 
of education influence participation barriers in clinical research. Improved understanding of 
predictors will offer insight on how to effectively engage and educate patients living in the 
southeastern United States who receive healthcare services through facilities associated with the 
STAR-CRN. Based on the reviewed evidence, the researchers hypothesize that race, trust level, 
and level of education are predictors of barriers to participation in clinical research.  
Review of Evidence 
 Extensive literature exists regarding participation barriers in research and variables that 
can influence a stakeholder’s willingness to participate. Barriers identified include the 
participant’s level of trust, access to research information, fear of the unknown or adverse 
effects, inconvenience, and reputation of researchers and research institutions (George, Duran, & 
Norris, 2014; Williams et al., 2010).  
Trust 
The concept of trust is discussed and examined in health care literature specifically due to 
relationship dynamics between healthcare professionals and patients (Dibben, Morris, & Lean, 
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2000; Hall et al., 2001; Hupcey, Penrod, Morse, & Mitcham, 2001; Goudge & Gilson, 2005). 
Trust is defined as the degree to which the patient relies, depends, and is confident in the 
provider (Armstrong, Ravenell, McMurphy, & Putt, 2007). Trust is present in situations of risk, 
uncertainty, or unequal status where there is a level of dependence on another individual 
(Kerasidou, 2017; Thielmann & Hilbig, 2015) creating a relationship of vulnerability (Hall et al., 
2001). In the case of a patient and medical researcher, an asymmetrical relationship exists 
between the researcher’s authority and patient role.  
Many variables identified throughout literature act as barriers and facilitators to 
participant trust in clinical research (George, Duran, & Norris, 2014). Barriers to trust include 
inadequate information regarding research studies, unethical behavior by the research team, and 
safety concerns (Ceballos et al., 2014; Cortes et al., 2017; Cunningham-Erves et al., 2016; 
George et al., 2014; Owens et al., 2013; Scharff et al., 2010; Williams et al., 2010). Many 
individuals believe that collected samples like blood, urine, saliva, or stool are unethically 
disposed of or used after the research study without permission (Ceballos et al., 2014; Kraft et 
al., 2018). In addition, study participants expressed fear of taking medications that would cause 
adverse effects (Cortes et al., 2017), receiving unnecessary surgery (Cortes et al., 2017), 
experiencing unintended consequences of the study (George et al., 2014), having personal 
information be used against the participant (Cortes et al., 2017; Scharff et al., 2010) and being 
treated like “guinea pigs” or “lab rats” (Cunningham-Erves et al., 2016, Durant et al., 2011, 
George et al., 2014; Owens et al., 2013; Scharff et al., 2010; Williams et al., 2010). 
Facilitators to participant trust in clinical research include the patient’s relationship with 
the research team (Burkett & Morris, 2014; Byrne et al., 2014; Cortes et al., 2017; George et al., 
2014; Getrich et al., 2013; Gupta et al., 2014; Kraft et al., 2018; Owens et al., 2013; Paquette & 
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Derrington, 2018; Scharff et al., 2010; Williams et al., 2010), a thorough and educational 
research consent process (Cortes et al., 2017; George et al., 2014; Kraft et al., 2018, Owens et al., 
2013), and extensive research study oversight (Kraft et al., 2018; Paquette & Derrington, 2018). 
Individuals are more likely to participate in a study if they feel well informed about the study and 
know they have the right to withdraw at any point (Cortes et al., 2017; George et al., 2014). 
Study participants report greater feelings of trust and willingness to participate in research 
knowing that researchers are being held accountable by leadership teams (Kraft et al., 2018; 
Paquette & Derrington, 2018). In addition, participants voiced wanting to know about the 
research funding and how the data library was being managed (Kraft et al; 2018; Williams et al., 
2010). Participants’ understanding of the research team behind the study facilitated greater trust 
by the participant (Kraft et al., 2018; Paquette & Derrington, 2018; Williams et al., 2010). 
Race and ethnicity 
Race and ethnicity are variables that not only influence patient participation in research 
but also influence trust. Due to historic and recent events of segregation, racism, and unequal 
civil rights, African Americans report less willingness to participate in research compared to 
Caucasians (Dunlop, Leroy, Logue, Glanz & Dunlop, 2011; Durant et al., 2011; George et al., 
2014; Kraft et al, 2018; Ma et al., 2012; Owens et al., 2013; Scharff et al., 2010; Westergaard et 
al., 2013; Williams et al., 2010). A variety of studies reference the Tuskegee Syphilis Study that 
was conducted from the 1930s to the 1970s that left the African American community fearful 
and distrusting in the process of research (Alsan & Wanamaker, 2018; Durant et al., 2011; 
George et al., 2014; Ma et al., 2012; Owens et al., 2013; Scharff et al., 2010; Williams et al., 
2010). The study permitted hundreds of adult AA men with syphilis to go untreated despite the 
availability of effective treatment, Penicillin (Alsan & Wanamaker, 2018). In addition, the 
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treatment of Henrietta Lacks and her family in the 1950s continues to alter the perspectives of 
AAs towards healthcare institutions and American society (Kraft et al., 2018). Henrietta Lacks 
was an AA woman whose cells, collected from a cervical cancer biopsy, were later developed 
into the HeLa cell line. HeLa cells were commercialized and highly profitable in the healthcare 
world, however, the Lacks family did not gain any profit from her biospecimen (Lee et al., 
2019). 
Hispanic individuals also face specific cultural and racial variables that influence 
participation in clinical research (Ceballos et al., 2014; Kraft et al., 2018; Ulrich et al., 2013; 
Westergaard et al., 2013). Some study participants expressed their willingness to participate in 
research but have limited understanding of the healthcare system due to immigration to the 
United States later in their lives (Ceballos et al., 2014; Kraft et al., 2018; Ulrich et al., 2013). In 
addition, individuals expressed fear of racial discrimination (Ceballos et al., 2014; Ulrich et al., 
2013; Westergaard et al., 2013) and misunderstanding due to language barriers (Ceballos et al., 
2014; Westergaard et al., 2013).  
Education 
An individual’s education level is discussed within research literature in the context of 
research participation. Education level affects an individual’s literacy and understanding (Asare, 
Flannery & Kamen, 2017), therefore theoretically affecting what a participant knows and 
understands about research. In one study measuring recruitment and participation in clinical 
research (n=5,154), individuals with increased levels of education, particularly college graduates, 
were more likely to participate (Baquet, Commiskey, Mullins & Mishra, 2006). The results were 
consistent with a different study where 97% of participants were college educated and reported 
favorable views of research and willingness to participate in clinical trials (Brewer et al., 2014).  
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In a study measuring African Americans’ willingness to participate in research before and after a 
pre-consent education session (n=192), individuals with a high school level of education or less 
were significantly more likely to participate in a clinical trial after receiving pre-consent 
education (Dunlop et al., 2011). Although past literature explores the relationship between 
education level and an individual’s participation in research, convincing evidence of the 
relationship between an individual’s education level and perspectives on research participation is 
lacking.  
Location 
Race, trust, and education are variables in this scholarly project because they are seen 
throughout literature as predictors to patient participation. Although barriers to research 
participation have been studied previously, further research is justified because there is 
geographic variation in research participation barriers throughout the United States (Armstrong 
et al., 2007). Individuals living in urban areas report greater distrust compared to those in rural 
areas, yet rural participants report lack of interest in participating in clinical trials compared to 
urban areas (Friedman, Bergeron, Foster, Tanner & Kim, 2013). In another study, participants 
living in rural Maryland were less likely to participate in research compared to participants living 
in urban Maryland (Baquet et al., 2006). Due to geographic variation, collecting data from 
patients who receive care from medical providers that belong in a specific healthcare network, 
specifically those affiliated with the STAR-CRN, can be beneficial for developing accurate 
implementation methods to engage that same population for research.  
Theoretical Model 
The Social Cognitive Theory (SCT) by Albert Bandura (1971) provided the theoretical 
framework for the scholarly project. The Social Learning Theory was initially developed in the 
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1960s while Bandura was studying the learned behaviors of children. The theory was later 
updated into the Social Cognitive Theory in 1986 (LaMorte, 2019). The theory explains how 
individuals learn and maintain behaviors in the social context in which they live.  The theory 
includes the construct of reciprocal determinism which considers the continual interaction 
between cognitive, environmental, and behavioral factors to ultimately determine human 
behavior (Ozylimaz, Erdogan, & Karaeminogullari, 2018). Cognitive factors, also called 
personal factors, include an individual’s knowledge, expectations, and attitudes. Environmental 
factors include societal and cultural norms, community access and resources, and the influence 
of others. Behavioral factors include skills, practice, and an individual’s self-efficacy.  
The triadic reciprocal relationship between cognitive factors, the environment, and human 
behavior explains the theorized relationship between variables in the scholarly project. Refer to 
Figure 1 for a model of the SCT in relation to the variables being examined. The independent 
variables of the scholarly project included the individual’s level of trust towards clinical 
research, race, and level of education. Each independent variable was classified as a personal 
factor within the theory.  Barriers to participating in research were the dependent variables of the 
scholarly project. One can assume if no barriers to participating exist, an individual would 
therefore participate in research. Participation in clinical research was classified as the behavior 
in the theoretical model. Environmental factors include the physical, social and cultural context 
in which an individual lives.  
Although the scholarly project did not directly include environmental factors as study 
variables, literature consistently displays that environmental factors are closely tied to race and 
trust level. Current and historic racism and societal segregation create neighborhoods and cities 
with unequal opportunities and resources.  When comparing communities with similar poverty 
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rates, neighborhoods that are predominantly African American or Hispanic have fewer grocery 
stores, parks, and gyms than predominately white neighborhoods (Brooks, 2014; Firebaugh & 
Acciai, 2016). In addition, African American men report greater perception of racial 
discrimination in health care compared to white men (Assari et al., 2017). As stated previously in 
the review of literature, past studies reveal that level of trust and willingness to participate in 
research varies geographically. Therefore, environmental factors, although not a variable that is 
being measured directly within the scholarly project, are directly tied to the variables of interest 
and require inclusion within the theoretical framework.  
In the context of the scholarly project, the researcher can theoretically predict behavior, as 
in, participation in clinical research, with consideration of the various factors that influence that 
human behavior. An individual who does not understand research or has little trust in medical 
research may be less likely to engage in research. Comparatively, an individual with greater 
amounts of trust towards medical research and a higher level of education may be more likely to 
participate in research.  
Project Design 
The scholarly project utilized secondary, cross sectional survey data that were collected 
between 2014 and 2016 through the former Mid-South Clinical Data Research Network 
(CDRN), currently known as the STAR-CRN. The surveys were handed out throughout clinics 
within the former Mid-South CDRN after receiving approval from the Vanderbilt University 
Institutional Review Board (IRB). To utilize the de-identified data for the scholarly project, the 
Belmont University IRB approved the project as exempt in April 2019.  
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Clinical Setting 
The former Mid-South CDRN conducted research across numerous healthcare delivery 
sites throughout the Southeastern US. The major medical sites associated with the former Mid-
South CDRN included Vanderbilt University Medical Center, Meharry Medical College, the 
Vanderbilt Healthcare Affiliated Network, Greenway Health, and the Carolinas Collaborative. 
Although the former Mid-South CDRN, now known as the STAR-CRN, is expansive 
throughout the southeast, the survey was specifically distributed to patients visiting a Vanderbilt 
University or Meharry/Metro General hospital or clinic. Practice settings of the former Mid-
South CDRN included, Vanderbilt University Medical Center, Vanderbilt University Children’s 
Hospital, Vanderbilt University Stallworth Rehabilitation Hospital, Vanderbilt University 
Psychiatric Hospital, Meharry/Metro General Hospital, and Matthew Walker Community Health 
Center.  
Project Population 
The research participants were adults (18 years old and older) living in the Southeastern 
United States who received care at least one time from a provider at one of the aforementioned 
clinical sites. There were no further inclusion or exclusion criteria.  
Data Collection Instruments 
Between 2014 and 2016, approximately 5,000 patients in the CDRN were surveyed to 
identify barriers that impede patient involvement in research. Two parallel surveys were 
administered using a random process (Cunningham-Erves, Villalta-Gil, Wallston, Boyer, & 
Wilkins, 2019). The surveys differed by tools that measured the concept of trust. One survey 
included the tool, Hall-Trust in Medical Research (Hall et al., 2006) while the other included 
Mainous-Trust in Medical Research (Mainous, Smith, Geesey, & Tilley, 2006). The Scholarly 
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Project only utilized data collected from the survey containing the tool, Trust in Medical 
Research (items 67-78) by Hall et al. (2006). All surveys were administered using REDCap 
(Harris et al., 2019). Refer to appendix A for a copy of the survey.  
Race, ethnicity, and level of education were collected in the demographic portion of the 
survey (items one through 24). The tool Trust in Medical Research (items 67 to 78) by Hall et al. 
(2006) was used to measure the respondent’s level of trust in medical research. The trust tool 
was developed initially through a pilot study with a 25-item questionnaire. It was then simplified 
by following an item-reduction procedure to develop the current 12-item tool (Hall et al., 2006).  
The Cronbach alpha coefficient was 0.87 and the response pattern was normally distributed (Hall 
et al., 2006).  
Questions to assess barriers to participation in medical research (items 54 to 66) were 
taken from a previous study by Mouton, Harris, Rovi, Solorzano, & Johnson (1995) using a five-
point Likert scale for each statement ranging from strongly agree to strongly disagree. The 
specific questions were created from a literature review of barriers to participation in research. A 
panel of four experts reviewed the 12- question instrument for clarity, content validity, and 
cultural sensitivity. The content validity and cultural sensitivity both scored as 1.0 (Millon-
Underwood, Sanders, & Davis, 1993). 
Data Collection Process 
Participants were recruited in person at the aforementioned clinics. Prior to receiving a 
survey, participants were informed of the purpose, time commitment, risks and benefits, and 
compensation. Compensation included a $25.00 gift card with the completion of the survey.  
The results of the survey were stored in a secure dataset through the Meharry Vanderbilt 
Alliance (MVA). In order for the project leader to access the secondary data, the Belmont 
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University IRB approval was obtained in April 2019. Next, a data-usage agreement through 
MVA was signed by the project leader. The project leader obtained the dataset in August 2019.   
Statistical Analysis 
 The dataset was organized and cleaned in Microsoft Excel. Initially, the dataset included 
4,700 respondents from two different surveys. The researcher removed the respondents from the 
dataset that did not obtain the survey that was used for the scholarly project. A total of 2,149 
respondents remained after deletion. The percentage of missing data was calculated for each 
survey measure. Each measure had less than 5% missing data. A response mean for each 
measure was calculated to fill in missing data.  
 IBM SPSS Statistics, version 26 was used for the statistical analysis. Descriptive statistics 
were performed on the variables of level of education, trust level, race, and each attitude 
statement in the barriers to participation scale. Next, a spearman rank correlation was performed 
between level of education, level of trust, and each attitude statement for each racial category. 
Results 
A total of 2,149 survey responses were used in the data analysis. Sociodemographic 
characteristics of survey respondents are shown in Table 1. The mean age of respondents was 52 
years old (SD=15.65) with majority being female (69.0%, n=1496), white (77.7%, n=1701), 
insured (76%, n=1610), and working full time (50.4%, n=1078). The mean trust score was 39.85 
(SD=6.7). Trust scores by racial grouping are shown in Table 2. Middle Easterners reported the 
least amount of trust (M=36.11, SD=5.8) compared to other groups. The majority of respondents 
had at least two years of college education (85.3%, n=1836). Education levels are separated by 
racial groupings in Table 3. Very few respondents in each racial grouping had less than an 8th 
grade education.   
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Overall, the respondents had favorable attitudes towards research participation. 
Percentage of respondent agreement towards attitude statements are displayed in Table 4. The 
majority of participants agreed that research benefits society and that participation in research 
means better care. Opposingly however, only 3.3% (n=51) of respondents agreed that research 
conducted in the United States is ethical.  Attitudes towards researchers were generally positive 
in that only a few, 5.5% (n=119), agreed that “Researchers don’t care about me” and “Scientists 
cannot be trusted” (2.4%, n=51).  
Spearman correlations were performed using the racial groupings of White, AA, 
Hispanic, Native American, Asian, and Middle Eastern. As mentioned previously in the project 
design section, the correlations utilized education, trust level, and attitudes regarding 
participating in research. Correlation results are displayed in Table 5. Correlations were not 
performed for the Native Hawaiian grouping due to a small sample size (n<5). Trust was 
significantly associated with agreement in each attitude statement from both white and AA 
respondents (p<.001), however association with education level was variable. Trust level was 
negatively associated with agreement towards the statement “Researchers don’t care about me” 
in White (CC=-.492; p=.000), AA (CC=-.188; p=.000), Asian (CC=-.429; p=.041), and Middle 
Eastern (CC=-.864; p=.003) respondents. Trust level was strongly associated with specific 
attitude statements for Native American respondents but there was less evidence of associations 
involving their education level.  Conversely in Asian respondents, education level was positively 
associated with the statements “Participation in research is morally wrong” (CC=.540; p=.008), 
“Scientists cannot be trusted” (CC=.568; p=.005), “Research conducted in the US is ethical” 
(CC=.453; p=.030), and “It is better to be treated by doctors who are researchers” (CC=.418; 
p=.047).  
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Discussion 
The purpose of the scholarly project was to determine how stakeholder race, trust, and 
level of education influence participation barriers in clinical research. Although the respondent’s 
attitude scores towards research participation is not the exact determination of whether the 
participant will or will not engage in clinical research, the attitude score may be considered a 
proxy for the act of engaging in clinical research. 
Overall, this cross-sectional survey of adults in the Southeastern US demonstrates 
favorable attitudes towards research participation. The data suggest that attitudes are positive in 
regard to perceived societal benefit and the belief that research leads to better medical care. The 
attitudes towards research are consistent with both the findings of Mouton et al (1995) and 
Brewer et al (2014). In addition, the research of Kraft et al (2018) displayed similar themes 
during focus group interviews of AAs, Chinese, Hispanic, White, and Asians who agreed that 
research would benefit society and in general, improve medical care. Although favorable 
attitudes towards research participation are seen within the data, the relationship of attitudes and 
an individual’s race, trust, and education is important to consider in the context of the theoretical 
framework of the project and implications for future clinical practice.  
Race and Ethnicity 
 No statistical tests were performed to analyze the correlation between race and attitudes 
towards research participation within the scholarly project. As explained previously in the 
methods section, the data was separated by racial groupings in order to consider race within 
statistical tests that do not allow for nominal variables. The scholarly project results display 
variability between racial groupings in education level, trust level, and attitudes towards 
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participating in research. One cannot assume, however, statistically correlated relationships 
between a respondent’s race and attitudes towards participating in research.  
The difference of trust and education between White, AA, Hispanic, NA, Asian, and MEs 
support the theoretical underpinnings of the scholarly project. The Social Cognitive Theory 
considers an individual’s personal factors like race and ethnicity, however, the predictive weight 
of the personal factor in direct correlation to participating in research is uncertain.  
Trust 
The findings of the scholarly project display strong evidence that an individual’s trust in 
clinical research influences one’s attitude towards research. In White, AA, Hispanic, NH, and 
ME respondents, trust is correlated more often to attitudes towards research than an individual’s 
education level. The findings are consistent with past literature displaying the significant role 
that trust has in a patient’s barriers and facilitators in participating in clinical research (George, 
Duran, & Norris, 2014). In addition, the findings support the original hypothesis that trust is 
predictive towards barriers in clinical research. As respondents agreed more to negative 
statements regarding participation like, “Researchers don’t care about me”, “Participation in 
research is risky”, and “Participation in research is morally wrong”, trust level was decreased. As 
respondents agreed more with the statements “Participation will mean better care”, “Participation 
in research is enjoyable”, and “Participation in research allows me to socialize”, trust level 
expectedly also increased.  
The relationship between trust and the respondent’s attitude towards research also aligns 
with the theorized relationship of variables explained through the Social Cognitive Theory. 
Through the theoretical model and the supporting data, stronger evidence exists to predict if an 
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individual has greater trust towards medical research, attitudes towards research are more 
favorable, and participation is more likely to occur.   
Education 
Overall, less evidence supported correlations between a participant’s level of education 
and attitude on research participation. These findings are generally inconsistent with past 
research regarding barriers to research participation. Past literature displays that low education 
levels can contribute to decreased research participation due to the difficulty of understanding 
the research information or the informed consent process (Asare, Flannery & Kamen, 2017; 
Baquet, Commiskey, Mullins & Mishra, 2006; Crosson, Eisner, Brown, & Ter Maat, 2001). In a 
qualitative survey of Hispanic beliefs about biomedical research participation, the researchers 
found that participants discussed not having a formal education which acted as a barrier for 
participating in research from fear of the unknown (Ceballos et al., 2014). However, the findings 
of the scholarly project display less evidence of a correlation between education level and 
attitudes towards research participation in Hispanic individuals.  
The results of the scholarly project suggest that education level may hold a stronger 
influence on attitudes towards research for Asian respondents compared to the influence of trust. 
The results contradict what is commonly discussed in medical literature regarding Asian 
American reverence and respect to healthcare providers (Gaw, 2020). Past literature expresses 
how language barriers and health literacy are common barriers for Asian Americans when 
navigating the healthcare system (Kim & Keefe, 2010; Tu et al., 2005) which may align with an 
individual’s education level, particularly if they were educated in the US.  
Generally, education level is not a largely predictive variable in its influence of research 
participation unlike what was hypothesized. Although it shows stronger evidence of influence 
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depending on race and attitude statement, it is not as consistent as the influence of trust level. 
The dynamic, reciprocal relationship between personal and environmental factors of the Social 
Cognitive Theory is important to consider in regard to the relationship of education level on an 
individual’s participation in research. Although education can have influence on an individual’s 
behavior, a variety of personal and environmental factors exist that may hold stronger influence 
towards behavior. The inconsistency of an individual’s education level on attitudes towards 
research participation within this scholarly project can ultimately highlight that numerous factors 
have the ability to play a role in research participation.  
Implications for Practice and Future Directions 
The findings of the scholarly project have several implications. The variability in results 
support the Social Cognitive Theory in that numerous factors influence an individual’s decision 
to participate in research. Clinicians must be aware of the factors that contribute to an 
individual’s attitude toward research and educate accordingly. A staggering 97% (n=2,079) of 
respondents within the dataset agreed that research conducted in the US is unethical. The results 
of this study are even more than Brewer et al (2014) of which half of survey respondents agreed 
that research in the US is unethical. As the results show, an individual can believe that research 
benefits society while also perceiving research to be unethical. The fear of unethical treatment 
may outweigh the altruistic motivation of how research benefits society, therefore hindering the 
participants’ engagement in research. Increased clinician education regarding the socio-cultural 
barriers that hinder patients from participating can enhance clinician-patient communication.  
Utilizing multiple recruitment methods for engaging participants may also be helpful. 
Researchers may consider engaging with community representatives, community networks, and 
churches to engage individuals (Luebbert & Perez, 2016). A newer model of research 
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engagement, community-based participatory research (CBPR), displays encouraging recruitment 
results (Scharff et al., 2010). CBPR operates on long term community-research relationships 
(Scharff et al., 2010) and can improve knowledge gaps within communities regarding disclosure 
and transparency, fear of research procedures, and societal impact in relation to research trials 
(Cortes et al., 2017). In one study, Chadiha et al., (2011) utilized a CBPR framework to build a 
research volunteer registry. The community-based recruitment initiatives increased the registry 
from 102 to 1,273 individuals enrolled (Chadiha et al., 2011). In addition, increased ethnographic 
research, particularly for highly underrepresented races and subgroups, may be helpful in 
recognizing barriers to participating in research that are not as culturally explicit (George, Duran, 
& Norris, 2014). 
Due to the overall favorable attitudes towards participating in research displayed in the 
scholarly project, it warrants the question if individuals are being exposed to research 
participation opportunities through their medical providers. The data collected by Pinto et al 
(2014) found that medical providers with greater education and experience were more involved 
in the recruitment and facilitation of research specifically with underrepresented populations. 
Patients, although possibly willing to participate in research, may have little to no knowledge of 
the trials occurring if providers have a more limited lens on research opportunities. In outpatient 
clinical settings, providers state that time constraints, forgetting to recruit, and the small number 
of eligible individuals act as barriers in recruiting patients into research (Page, French, 
McKenzie, O’Connor & Green, 2011).  
The findings from the scholarly project can be used to enhance the ongoing efforts of 
recruiting and engaging participants, specifically underrepresented populations, in clinical 
research. It would be beneficial to consider clinician’s effectiveness with recruitment efforts 
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based on practice setting. The distribution of medical providers varies depending on rural and 
urban regions and specialty care settings (AHRQ, 2012).  Currently, more physicians are 
practicing in urban, specialty areas compared to Physician Assistant’s and Nurse Practitioners 
who are more commonly in rural and primary care settings (AHRQ, 2012). It is possible that 
providers who are working within academic or large medical centers in urban areas have greater 
exposure to research engagement opportunities for their patients compared to more community-
based providers. In addition to provider exposure to research recruitment efforts, the scholarly 
project warrants greater exploration in the role of Doctor of Nursing Practice (DNP)- 
practitioners within the context of research. The DNP role functions to support the closure of the 
research-practice gap, specifically by exploring evidence-based research questions grounded in 
clinical practice (Weierbach, Glick, Fletcher, Rowlands, & Lyder, 2011). For DNPs, research 
initiatives or recruitment may be easier because the practitioner is trained with a greater lens for 
research.  
Limitations 
In light of this study’s strengths, several limitations are acknowledged. Sampling bias is 
possible in that individuals holding negative attitudes toward research participation were less 
likely to complete a survey and are therefore underrepresented in the sample. The data were 
collected between 2014 and 2016, therefore it is becoming more outdated. In addition, due to the 
nature of utilizing a secondary data source, a precise response rate is unable to be calculated. In 
order to understand the relationship between variables, Spearman’s correlation was an 
appropriate statistical test. However, performing a correlation between every attitude score, trust 
level, and education level for each racial category allows for greater opportunities for false 
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positives. Cross-sectional research designs allow for correlational analyses; however, it is 
difficult to derive a causal relationship between variables.  
Conclusion 
Engaging and recruiting participants, particularly from minority populations, in clinical 
research is a national priority. Research allows for increased knowledge in healthcare delivery 
and treatment which ultimately allows for effective, equitable, and patient centered care. Without 
diversity in research participants, the health disparities already occurring within minority 
populations will only worsen. The results of the scholarly project, aligned with past literature, 
support the importance of trust within the patient and provider relationship and that numerous 
variables contribute to a patient’s attitude towards participating in research. Medical providers 
involved in recruiting and engaging participants in research must have heightened awareness, 
consideration, and appreciation of the complex relationships of personal and environmental 
factors that make a participant and their attitudes, specifically towards research, unique.  
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Figure 1. Core concepts of the Social Cognitive Theory with variables used in the scholarly 
project.  
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Appendix 1.  
 
  
The first set of questions tells us about you and your background.  
 
 
1.  
 
What is the year of your birth 
 
 Year___________ 
 
2.  What is your race or ethnicity (Check all that apply) 
Other, please specify 
 Asian (i.e. Asian Indian, 
Chinese, Filipino, Japanese, 
Korean, Vietnamese, Hmong, 
Laotian, Thai, Pakistani, 
Cambodian, etc.) 
 Black, African American, 
African, or Afro-Caribbean 
 Hispanic, Latino, Spanish 
origin 
 Middle Eastern/North African 
 Native American, American 
Indian, Alaskan Native 
 Native Hawaiian, Samoan 
 White 
 Some other race, please 
specific 
 Prefer not to answer 
3.  What is your sex 
If other, please specify: 
 Male 
 Female 
 Other 
 Prefer not to answer 
4.  What is your marital status?  Now married 
 Living with a partner or 
significant other 
 Widowed 
 Divorced 
 Separated 
 Never married 
 Prefer not to answer 
5.  What is the highest degree or level of school you completed?  8th grade or less 
 Some high school, but did not 
graduate 
 High school graduate or GED 
 Some college or 2 year degree 
 Prefer not to answer 
6.  Are you currently:   Employed Full Time (32+ 
hours a week) 
 Employed Part Time (less 
than 32 hours per week 
 Unemployed 
 Volunteer 
 Stay-at-home parent 
 Retired 
 Receiving disability 
 Other, Please Specify___ 
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7.  How many people live in your home (including yourself)?  ______________ 
8.  Have you visited your doctor in the past year?  Yes 
 No 
9.  If yes, please select the clinic  Vanderbilt University 
Medical Center 
 Vanderbilt University 
Children’s Hospital  
 Vanderbilt University 
Stallworth Rehabilitation 
Hospital 
 Vanderbilt University 
Psychiatric Hospital 
 Vanderbilt University 
Outpatient Practices 
 Meharry/Metro General 
Hospital 
 Matthew Walker Community 
Health Center 
 Prefer not to answer 
 Other, _______ 
10. Do you have a cell phone?  Yes 
 No 
11. How often do you text?  Not at all 
 Not often 
 Somewhat often 
 Often 
 Very Often 
12. Can you access the internet using your phone?  Yes 
 No 
13. Do you have access to the internet at home?  Yes 
 No 
14. How confident are you using computers?  Very confident 
 Confident 
 Fairly Confident 
 Not Confident 
 Prefer not to say 
  
Many patients have trouble understanding the medical information they get at the hospital or 
doctor’s office.  
 
15.  How confident are you filling out medical forms by 
yourself? 
 Extremely 
 Quite a bit 
 Somewhat 
 A little bit 
 Not at all 
 
16. How often do you have someone help you read hospital 
materials? 
 All of the time 
 Most of the time 
 Some of the time 
 A little of the time 
 None of the time 
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17. How often do you have problems learning about your 
medical conditions because of difficulty understanding 
written information? 
 All of the time 
 Most of the time 
 Some of the time 
 A little of the time 
 None of the time 
 
The next few questions ask about your experience and feelings about working with numbers.  
 
18. How good are you at working with fractions?  Not at all good/Not at all 
often 
 Pretty good/Somewhat often 
 Good/Often 
 Very good/Very Often 
 Extremely good/extremely 
often 
19. How good are you at figuring out how much a shirt will cost 
if it is 25% off? 
 Not at all good/Not at all 
often 
 Pretty good/Somewhat often 
 Good/Often 
 Very good/Very Often 
 Extremely good/extremely 
often 
20. How often do you find numerical information to be useful?  Not at all good/Not at all 
often 
 Pretty good/Somewhat often 
 Good/Often 
 Very good/Very Often 
 Extremely good/extremely 
often 
  
How familiar are you with the following words or phrases? 
 
21. Genetic Testing  Not at all familiar 
 Slightly familiar 
 Somewhat familiar 
 Moderately familiar 
 Extremely familiar 
22. Biological Indicators/Biomarkers  Not at all familiar 
 Slightly familiar 
 Somewhat familiar 
 Moderately familiar 
 Extremely familiar 
23. Precision Medicine  Not at all familiar 
 Slightly familiar 
 Somewhat familiar 
 Moderately familiar 
 Extremely familiar 
24. Pharmacogenetics  Not at all familiar 
 Slightly familiar 
 Somewhat familiar 
 Moderately familiar 
 Extremely familiar 
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To help guide future research and healthcare, how important are the following to you? 
 
 
25. My healthcare is specific to me. No two cases are the same.   Not at all important 
 Slightly important 
 Somewhat important 
 Moderately important 
 Extremely Important  
 
26. My genes can be used to determine the best treatment for 
me. 
 Not at all important 
 Slightly important 
 Somewhat important 
 Moderately important 
 Extremely Important  
 
27. My genes and other health information can be used to help 
prevent or treat health conditions in my family.  
 Not at all important 
 Slightly important 
 Somewhat important 
 Moderately important 
 Extremely Important  
 
28. My health information is kept private and secure 
 
 
 Not at all important 
 Slightly important 
 Somewhat important 
 Moderately important 
 Extremely Important  
 
29. I have access to my own health records and can decide 
which health care providers and researchers have access to 
them.  
 Not at all important 
 Slightly important 
 Somewhat important 
 Moderately important 
 Extremely Important  
 
30. I can add information about my health to my health 
records.  
 Not at all important 
 Slightly important 
 Somewhat important 
 Moderately important 
 Extremely Important  
 
31. Do you have any of the following? Check all that apply  No health conditions 
 High Blood Pressure 
 Heart Disease 
 Heart Attack 
 Overweight or obese 
 Diabetes 
 Asthma 
 Sickle Cell Disease 
 Other 
 Prefer Not to Say 
32. Household income  Less than $10,000 
 $10,000-$14,999 
 $15,000-$44,999 
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 $25,000-$34,999 
 $35,000-$49,999 
 $50,000-$74,999 
 $75,000-$994,999 
 $100,000-$149,999 
 $150,000 or more 
33. Health Insurance Category  Insured 
 Uninsured (No Insurance) 
 Medicaid (TennCare) 
 Medicare 
 Self Pay 
 Other 
  
 
The next set of questions tells us about your experience with research.  
 
 
34. Prior to today, have you ever been asked to participate in 
research? 
 Yes 
 No 
35. Prior to today, have you ever participated in health-related 
research? 
 Yes 
 No 
36. If yes, how would you describe the research?  A study comparing treatments 
or prevention methods 
(clinical trial) 
 Testing to determine if you 
are high risk for a certain 
disease 
 Testing to determine if a 
condition has been passed 
down in your family 
(inherited) 
 In person-focus group, 
facilitated discussion or 
survey of attitudes, beliefs, or 
behaviors 
 An online questionnaire or 
survey of attitudes, beliefs or 
behaviors 
 Blood, tissue, or other body 
fluid was collected for use in 
any current or future research 
 Other 
37. In general, what would be the preferred contact methods to 
learn about potential research studies? Select all that apply.  
 Email 
 Cell phone text 
 Social media (Facebook or 
twitter) 
 Letter or postcard in the mail 
 A computer created phone 
message 
 Personal phone call from 
research staff or my doctor 
 Talking face to face 
 Other 
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 I am not interested in being 
contacted about future 
research studies 
  
 
If a research study was studying a condition or health problem that you care about, would you 
participate if it required…. 
 
 
38. Completing a survey two or more times  Not Interested 
 Somewhat Interested 
 Very Interested 
39. Giving a blood sample  Not Interested 
 Somewhat Interested 
 Very Interested 
40. Taking part in a study that involves by phone or over the 
internet (for example, to get advice about your health) 
 Not Interested 
 Somewhat Interested 
 Very Interested 
41. Taking part in a study that involves meeting at a local 
community center or school 
 Not Interested 
 Somewhat Interested 
 Very Interested 
42. Taking part in a study that involves you and other people in 
your family 
 Not Interested 
 Somewhat Interested 
 Very Interested 
43. Taking part in a study in which you would stay in the 
hospital for one or more days 
 Not Interested 
 Somewhat Interested 
 Very Interested 
44. What sources do you most often use to find information 
about health or medical topics? Check all that apply.  
 Family 
 Friend/Co-worker 
 Doctor or other health care 
professional 
 Internet 
 Radio, newspaper or 
magazine 
 Telephone, information 
number of disease-focused 
group such as the American 
Cancer Society or the 
American Heart Association 
 Complementary, alternative 
or unconventional practitioner 
 I have never looked for 
information about health or 
medical topics 
 Other, please 
describe_______ 
  
 
In general, how much do you trust information about health or medical topics from each of the 
following? 
 
 
45. Doctor  Not at all 
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 A little 
 Some 
 A lot 
46. Other healthcare provider (nurse, pharmacist, or other 
professional who provides care) 
 Not at all 
 A little 
 Some 
 A lot 
47. Family or friend  Not at all 
 A little 
 Some 
 A lot 
48. Online community for patients or caregivers dealing with 
the same health condition 
 Not at all 
 A little 
 Some 
 A lot 
49. Disease-focused groups such as the American Cancer 
Society or the American Heart Association 
 Not at all 
 A little 
 Some 
 A lot 
50. Your health insurance company  Not at all 
 A little 
 Some 
 A lot 
51. Internet  Not at all 
 A little 
 Some 
 A lot 
52. Television, radio, newspaper, or magazines  Not at all 
 A little 
 Some 
 A lot 
53. Government health agencies  Not at all 
 A little 
 Some 
 A lot 
  
 
Please indicate to what degree you agree or disagree with the following statements regarding 
participation in research 
 
 
54. Please indicate to what degree you agree or disagree with 
the following statements regarding participation in research 
 
Participation in clinical research benefits society 
 Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
55. Participation will mean better care  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
56. Participation in research is risky  Strongly disagree 
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 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
57. Researchers do not care about me  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
58. Participation in research is enjoyable  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
59. Participation in research allows me to socialize  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
60. Participation in research is against my religion  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
61. Participation in research is morally wrong  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
62. Transportation is a problem for people who participate  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
63. Scientists cannot be trusted  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
64. It is better to be treated by doctors who are researchers  Strongly disagree 
 Disagree 
 Neither agree nor disagree 
 Agree 
 Strongly Agree 
65. Which of the following are barriers for you when 
considering participating in research? Check all that apply 
 Technical language on study 
materials (i.e. flyers, 
brochures, text messages, 
consent form, etc.) 
 Cultural appropriateness of 
study materials (i.e. flyers, 
brochures, text messages, 
consent form, etc.) 
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 Burden to yourself or your 
family (i.e. time, cost, social 
acceptance) 
 The feeling of being 
undervalued or poorly treated 
by health care system 
 Limited access to research 
studies 
 Personal attitude towards 
research in general 
 Limited resources to 
participate in research (i.e. 
transportation, phone, 
internet, etc.) 
 Lack of sensitivity from the 
researcher 
 Lack of trust/mistrust/distrust 
 Lack of 
motivation/willingness 
 Fear 
 Religious/spiritual beliefs 
 Lack of awareness of studies 
(i.e. poor advertisement in 
your environment) 
 The feeling that your health 
condition is stigmatized by 
society/health system/health 
providers (i.e. obesity, mental 
health, etc.) 
 Restricted eligibility criteria 
(i.e. being turned away 
because you did not fit the 
screening criteria) 
 Other 
 
66. In my opinion, research in the United States is  Ethical 
 Not Ethical 
 Don’t know 
 Other 
  
 
The following 12 questions ask about your views on research. There are no right or wrong answers. 
For each statement below, please indicate how strong you agree or disagree with it.  
 
 
67. Doctors who do medical research care only about what is 
best for the patient 
 Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
68. Medical researches treat people like “guinea pigs”  Strongly disagree 
 Disagree 
 Neutral 
 Agree 
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 Strongly Agree 
69. It’s safe to be in a medical research study  Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
70. Some doctors do medical research for selfish reasons  Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
71. Doctors tell their patients everything they need to know 
about being in a research study 
 Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
72. A doctor would never ask me to be in a medical research 
study if the doctor thought there was any chance it might 
harm me.  
 Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
73. There are some things about medical research that I do not 
trust at all.  
 Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
74. A doctor would never recommend something that is not the 
best treatment just so he or she can study how it works 
 Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
75. Medical researchers have no selfish reasons for doing 
research studies 
 Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
76. Medical researchers do not tell people everything they 
really need to know about being in a research study 
 Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
77. The only reason doctors do medical research is to help 
people 
 Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
78. I completely trust doctors who do medical research  Strongly disagree 
 Disagree 
 Neutral 
 Agree 
 Strongly Agree 
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Table 1 
Sociodemographic characteristics of survey respondents (N=2,149) 
 
Characteristic n % 
Gender 
Male 
Female 
Other 
 
640  
1496 
6 
 
29.0 
69.0 
0.3 
Race 
White 
African American 
Hispanic 
Native American 
Asian 
Prefer not to answer 
Middle Eastern 
Native Hawaiian 
 
1701 
341 
57 
40 
23  
14 
9  
4  
 
77.7 
15.6 
2.6 
1.9 
<1 
<1 
<1 
<1 
Education 
8th grade or less 
Some high school did not graduate 
High school graduate or GED 
Some college or 2-year degree 
College degree 
More than a college degree 
Prefer not to answer 
 
17  
59 
214  
543  
622  
671  
16  
 
0.8 
2.7 
9.9 
25.2 
28.8 
31.3 
0.7 
Employment 
Full Time 
Part Tim (<32hr) 
Unemployed 
Volunteer 
Stay at home parents 
Retired 
Receiving disability 
Other 
 
1078 
193 
108 
22  
87  
351  
158  
143  
 
50.4 
9.0 
5.0 
1.0 
4.1 
16.4 
7.4 
6.7 
Insurance 
Insured 
Uninsured 
Medicaid 
Self-Pay 
Other 
 
1610  
68  
73  
318  
37  
 
76.0 
3.2 
3.4 
15.0 
1.7 
Household Income 
<$10,000 
$10,000-$14,999 
15,000-24,999 
25,000-34,999 
35,000-49,999 
 
142  
72  
136 
197  
233  
 
7.5 
3.8 
7.2 
10.4 
12.3 
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Note. n = frequency; M= Mean; SD = standard deviation 
50,000-74,999 
75,000-99,999 
100,000-149,999 
150,000 or more 
356 
288 
260 
218 
18.7 
15.1 
13.7 
11.5 
Table 2 
Trust statistics by racial grouping 
 
Race             Trust 
  
M 
 
SD 
All 
White 
African American 
Hispanic 
Native American 
Asian 
Prefer not to answer 
Middle Eastern 
Native Hawaiian 
39.85  
40.33  
37.79  
37.92  
37.85 
40.26 
40.36 
36.11 
40.22 
6.7 
6.6 
6.7 
7.3 
6.8 
4.9 
6.6 
5.8 
9.4 
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Table 3 
Education level by racial grouping 
 
 
 
Education Level 
 Race 
Total 
(N=2149) 
White 
(n=1701) 
African 
American 
(n=341) 
Hispanic 
(n=57) 
Native 
American 
(n=40) 
Asian 
(n=23) 
Middle 
Eastern 
(n=9) 
Native 
Hawaiian 
(n=4) 
Prefer not 
to answer 
(n=14) 
n % n % n % n % n % n % n % n % n % 
8th grade or less 17 0.8 4 0.2 12 3.5 - - - - - - - - - - - - 
Some high 
school did not 
graduate 
59 2.8 19 1.1 35 10.3 3 5.3 1 42.5 - - - - - - - - 
High school 
graduate or 
GED 
214 9.9 149 8.8 61 17.9 5 8.8 6 15.0 - - - - - - - - 
Some college or 
2-year degree 
543 25.2 440 25.9 80 23.5 11 19.3 16 40.0 6 26.1 1 11.1 1 25.0 5 35.7 
College degree 622 29.0 515 30.3 76 22.3 23 40.4 7 17.5 7 30.4 2 22.2 3 75.0 3 21.4 
More than a 
college degree 
671 31.1 567 33.3 72 21.1 13 22.8 10 25.0 9 39.1 6 66.7 - - 5 35.7 
Prefer not to 
answer 
16 0.7 7 0.4 5 1.5 2 3.5 - - 1 4.3 - - - - 1 7.1 
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Table 4 
Percentage of survey respondents reporting agreement with each attitude statement 
 
 
Research participation attitude statement 
 
Agreement (N=2149) 
 n % 
Participation in research benefits society 1954 
 
90.9 
Participation in research will mean better care 1649 76.7 
Participation in research is risky 532 24.8 
Researchers don’t care about me 119 5.5 
Participation in research is enjoyable 731 34.0 
Participation in research allows me to socialize 379 17.6 
Participation in research is against my religion 35 1.6 
Participation in research is morally wrong 33 1.5 
Transportation is a problem for research participants 357 16.6 
Scientists cannot be trusted 51 2.4 
Research conducted in the US is ethical 70 3.3 
It is better to be treated by doctors who are researchers 687 31.9 
Note: Agreement combines the responses: “agree” and “strongly agree.” 
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Table 5 
Spearman correlations between attitude statements, trust score, and education level by each racial category 
 
 
Statement 
 
White 
 (n=1701) 
African American 
(n=341) 
Hispanic 
(n=57) 
Native American 
(n=40) 
Asian 
(n=23) 
Middle Eastern 
(n=9) 
Trust Education Trust Education Trust Education Trust Education Trust Education Trust Education 
Participation in 
research 
benefits society 
CC .281** 
.000 
CC .182** 
.000 
CC .225** 
.000 
CC .293** 
.000 
CC .96 
.140 
CC .241 
.071 
CC .137 
.392 
CC .289 
.071 
CC .193 
.377 
CC .067 
.760 
CC -.087 
.823 
CC .207 
.593 
Participation in 
research will 
mean better 
care 
CC .333** 
.000 
CC.024 
.323 
CC .331** 
.000 
CC: .037 
.499 
CC .388** 
.003 
CC .146 
.278 
CC .443** 
.004 
CC .114 
 .483 
CC .181 
.409 
CC .019 
.930 
CC -.276 
.472 
CC .245 
.524 
Participation in 
research is 
risky 
CC -.238** 
 .000 
CC -.082** 
.001 
CC -.154** 
 .004 
CC .139* 
 .010 
CC -.021 
 .877 
CC -.218 
.104 
CC -.311* 
.048 
CC .115 
.481 
CC -.245 
.260 
CC .115 
.601 
CC -.315 
.410 
CC .000 
1.0 
Researchers 
don’t care 
about me 
CC -.492** 
 .000 
CC -.035 
 .154 
CC -.188* 
 .000 
CC -.068 
.208 
CC -.305* 
.020 
CC .140 
.300 
CC -.567** 
.000 
CC .067 
.681 
CC -.429* 
.041 
CC .346 
.106 
CC-.864** 
.003 
CC .245 
.525 
Participation in 
research is 
enjoyable 
CC .312** 
.000 
CC .054* 
 .025 
CC .249** 
.000 
CC -.007 
.903 
CC .445** 
.000 
CC -.085 
.530 
CC .429** 
.005 
CC -.203 
.208 
CC .057 
.796 
 
CC .123 
.575 
CC .678* 
.045 
CC .371 
.325 
Participation in 
research allows 
me to socialize 
CC .165** 
.000 
CC -.108** 
.000 
CC .222** 
.000 
CC -.083 
 .126 
CC .283* 
.031 
CC -.085 
.530 
CC .416** 
.007 
CC -.226 
.161 
CC -.074 
.738 
CC .028 
.897 
CC .180 
.644 
CC -.491 
.179 
Participation in 
research is 
against my 
religion 
CC -.201** 
 .000 
CC -.144** 
.000 
CC-.117* 
 .029 
CC -.122* 
.024 
CC -.056 
.676 
CC -.176 
.191 
CC.149 
.352 
CC .032 
.843 
CC -.248 
.255 
CC .235 
.280 
CC .000 
1.0 
CC -.546 
.129 
Participation in 
research is 
morally wrong 
CC -.230** 
.000 
CC -.152** 
.000 
CC-.119* 
.026 
CC -.128* 
.018 
CC -.144 
.280 
CC -.342** 
.009 
CC .314* 
.046 
CC -.064 
.696 
CC -.279 
.198 
CC .540** 
.008 
CC -.052 
.894 
CC -.124 
.751 
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Transportation 
is a problem for 
research 
participants 
CC -.222** 
.000 
CC .018 
.464 
CC -.146** 
.006 
CC -.036 
.506 
CC .041 
.757 
CC -.152 
.260 
CC -.285 
.071 
CC -.146 
.369 
CC .067 
.761 
CC -.381 
.073 
CC .347 
.361 
CC -.220 
.569 
Scientists 
cannot be 
trusted 
CC -.395** 
.000 
CC -.163** 
.000 
CC -.236** 
.000 
CC -.105 
.052 
CC -.233 
.092 
CC -.173 
.198 
CC -.303 
.054 
CC .102 
.532 
CC -.148 
.501 
CC .568** 
.005 
CC -.663 
.052 
CC -.161 
.680 
Research 
conducted in 
the US is 
ethical 
CC -.328** 
.000 
CC -.116** 
.000 
CC -.171** 
-.001 
CC -.236** 
.000 
CC -.497** 
.000 
CC .144 
.284 
CC .001 
.995 
CC .256 
.110 
CC -.124 
.572 
CC .453* 
.030 
CC -.522 
.150 
CC .371 
.325 
It is better to be 
treated by 
doctors who are 
researchers 
 
CC .101** 
.000 
CC .041 
.089 
CC .106* 
.047 
CC -.010 
.850 
CC .115 
.390 
CC .084 
.535 
CC .049 
.759 
CC -.240 
.137 
CC -.246 
.258 
CC .418* 
.047 
CC .518 
.153 
CC -.068 
.862 
 
 
Note: CC is Spearman Correlation Coefficient.  
Second value is p value. *p<.05, **P<.01 
Attitude statements are scored toward agreement, level of trust is scored such that higher scores indicate greater respondent trust in medical research 
 
 
 
 
